CEL-SCI CORPORATION Share-based Payment Arrangement, Amount Capitalized
CEL-SCI CORPORATION (CVM) reported Share-based Payment Arrangement, Amount Capitalized of $6.29 million for the 12-month period ending 2023-09-30, per its 10-K filed 2023-12-21.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement
us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount · last filed 2023-12-21
- CEL-SCI CORPORATION share-based payment arrangement, amount capitalized for the quarter ending 2018-12-31 was $573.66K, a 60.39% decline year-over-year.
- CEL-SCI CORPORATION share-based payment arrangement, amount capitalized for the quarter ending 2018-09-30 was $549.87K, a 45.63% increase year-over-year.
- CEL-SCI CORPORATION share-based payment arrangement, amount capitalized for the quarter ending 2018-06-30 was $465.49K, a 43.15% increase year-over-year.
- CEL-SCI CORPORATION share-based payment arrangement, amount capitalized for the quarter ending 2018-03-31 was $279.82K, a 23.42% decline year-over-year.
- CEL-SCI CORPORATION share-based payment arrangement, amount capitalized for fiscal 2023 was $6.29M, a 44.81% decline from fiscal 2022.
- CEL-SCI CORPORATION share-based payment arrangement, amount capitalized for fiscal 2022 was $11.39M, a 16.77% decline from fiscal 2021.
- CEL-SCI CORPORATION share-based payment arrangement, amount capitalized for fiscal 2021 was $13.69M, a 35.32% increase from fiscal 2020.
- CEL-SCI CORPORATION share-based payment arrangement, amount capitalized for fiscal 2020 was $10.11M, a 128.38% increase from fiscal 2019.
| Period end | Share-based Payment Arrangement, Amount Capitalized 3 month | Share-based Payment Arrangement, Amount Capitalized 3 month as first filed | Share-based Payment Arrangement, Amount Capitalized 6 month | Share-based Payment Arrangement, Amount Capitalized 9 month | Share-based Payment Arrangement, Amount Capitalized 12 month |
|---|---|---|---|---|---|
| 2023-09-30 | $6.29M 10-K · filed 2023-12-21 | ||||
| 2022-09-30 | $11.39M 10-K · filed 2023-12-21 | ||||
| 2021-09-30 | $13.69M 10-K · filed 2022-12-27 | ||||
| 2020-09-30 | $10.11M 10-K · filed 2021-12-21 | ||||
| 2019-09-30 | $4.43M 10-K · filed 2020-12-29 | ||||
| 2018-12-31 | $573.66K 10-Q · filed 2019-02-14 | $1.12M derived: sum of 2 quarters · filed 2019-12-23 | $1.59M derived: sum of 3 quarters · filed 2019-12-23 | $1.87M derived: sum of 4 quarters · filed 2019-12-23 | |
| 2018-09-30 | $549.87K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-12-23 | $1.02M derived: sum of 2 quarters · filed 2019-12-23 | $1.30M derived: sum of 3 quarters · filed 2019-12-23 | $2.74M 10-K/A · filed 2019-12-23 | |
| 2018-06-30 | $465.49K 10-Q · filed 2018-08-14 | $745.30K derived: sum of 2 quarters · filed 2018-08-14 | $2.19M 10-Q · filed 2018-08-14 | $2.57M derived: sum of 4 quarters · filed 2019-02-14 | |
| 2018-03-31 | $279.82K 10-Q · filed 2018-05-15 | $1.73M 10-Q · filed 2018-05-15 | $2.11M derived: sum of 3 quarters · filed 2019-02-14 | $2.43M derived: sum of 4 quarters · filed 2019-02-14 | |
| 2017-12-31 | $1.45M 10-Q · filed 2019-02-14 | $1.83M derived: sum of 2 quarters · filed 2019-02-14 | $2.15M derived: sum of 3 quarters · filed 2019-02-14 | $2.52M derived: sum of 4 quarters · filed 2019-02-14 | |
| 2017-09-30 | $377.58K derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-19 | $702.75K derived: sum of 2 quarters · filed 2018-12-19 | $1.07M derived: sum of 3 quarters · filed 2018-12-19 | $1.38M 10-K · filed 2018-12-19 | |
| 2017-06-30 | $325.17K 10-Q · filed 2018-08-14 | $690.55K derived: sum of 2 quarters · filed 2018-08-14 | $1.00M 10-Q · filed 2018-08-14 | $1.85M derived: sum of 4 quarters · filed 2018-08-14 | |
| 2017-03-31 | $365.38K 10-Q · filed 2018-05-15 | $677.75K 10-Q · filed 2018-05-15 | $1.53M derived: sum of 3 quarters · filed 2018-05-15 | $1.95M derived: sum of 4 quarters · filed 2018-05-15 | |
| 2016-12-31 | $312.38K 10-Q · filed 2018-02-12 | $1.16M derived: sum of 2 quarters · filed 2018-02-12 | $1.58M derived: sum of 3 quarters · filed 2018-02-12 | $2.00M derived: sum of 4 quarters · filed 2018-02-12 | |
| 2016-09-30 | $849.77K derived: 10-K 12 month − 10-Q/A 9 month · filed 2017-12-29 | $1.27M derived: sum of 2 quarters · filed 2017-12-29 | $1.69M derived: sum of 3 quarters · filed 2017-12-29 | $2.11M 10-K · filed 2017-12-29 | |
| 2016-06-30 | $418.56K 10-Q/A · filed 2017-12-11 | $835.75K derived: sum of 2 quarters · filed 2017-12-11 | $1.26M 10-Q/A · filed 2017-12-11 | $1.62M derived: sum of 4 quarters · filed 2017-12-11 | |
| 2016-03-31 | $417.19K 10-Q/A · filed 2017-12-11 | $845.10K 10-Q/A · filed 2017-12-11 | $1.20M derived: sum of 3 quarters · filed 2017-12-11 | $1.82M derived: sum of 4 quarters · filed 2017-12-11 | |
| 2015-12-31 | $247.91K 10-Q/A · filed 2017-12-11 | $427.91K 10-Q · filed 2016-02-09 | $782.74K derived: sum of 2 quarters · filed 2017-12-11 | $1.40M derived: sum of 3 quarters · filed 2017-12-11 | $2.29M derived: sum of 4 quarters · filed 2017-12-11 |
| 2015-09-30 | $534.83K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-12-11 | $1.15M derived: sum of 2 quarters · filed 2017-12-11 | $2.05M derived: sum of 3 quarters · filed 2017-12-11 | $5.11M 10-K/A · filed 2017-12-11 | |
| 2015-06-30 | $619.14K 10-Q · filed 2016-08-09 | $1.51M derived: sum of 2 quarters · filed 2016-08-09 | $4.57M 10-Q · filed 2016-08-09 | $7.04M derived: sum of 4 quarters · filed 2017-12-11 | |
| 2015-03-31 | $892.06K 10-Q · filed 2016-05-10 | $3.95M 10-Q · filed 2016-05-10 | $6.42M derived: sum of 3 quarters · filed 2017-12-11 | $6.88M derived: sum of 4 quarters · filed 2017-12-11 | |
| 2014-12-31 | $3.06M 10-Q · filed 2016-02-09 | $5.53M derived: sum of 2 quarters · filed 2017-12-11 | $5.99M derived: sum of 3 quarters · filed 2017-12-11 | $6.51M derived: sum of 4 quarters · filed 2017-12-11 | |
| 2014-09-30 | $2.47M derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-12-11 | $2.93M derived: sum of 2 quarters · filed 2017-12-11 | $3.45M derived: sum of 3 quarters · filed 2017-12-11 | $3.96M 10-K/A · filed 2017-12-11 | |
| 2014-06-30 | $462.70K 10-Q · filed 2015-08-07 | $982.86K derived: sum of 2 quarters · filed 2015-08-07 | $1.49M 10-Q · filed 2015-08-07 | $2.04M derived: sum of 4 quarters · filed 2015-12-11 | |
| 2014-03-31 | $520.15K 10-Q · filed 2015-05-08 | $1.03M 10-Q · filed 2015-05-08 | $1.58M derived: sum of 3 quarters · filed 2015-12-11 | $2.14M derived: sum of 4 quarters · filed 2015-12-11 | |
| 2013-12-31 | $510.28K 10-Q · filed 2015-02-06 | $1.06M derived: sum of 2 quarters · filed 2015-12-11 | $1.62M derived: sum of 3 quarters · filed 2015-12-11 | $2.18M derived: sum of 4 quarters · filed 2015-12-11 | |
| 2013-09-30 | $549.19K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-11 | $1.11M derived: sum of 2 quarters · filed 2015-12-11 | $1.67M derived: sum of 3 quarters · filed 2015-12-11 | $2.64M 10-K · filed 2015-12-11 | |
| 2013-06-30 | $564.37K 10-Q · filed 2014-08-08 | $1.12M derived: sum of 2 quarters · filed 2014-08-08 | $2.09M 10-Q · filed 2014-08-08 | $2.59M derived: sum of 4 quarters · filed 2014-12-23 | |
| 2013-03-31 | $556.76K 10-Q · filed 2014-05-12 | $1.52M 10-Q · filed 2014-05-12 | $2.03M derived: sum of 3 quarters · filed 2014-12-23 | $2.49M derived: sum of 4 quarters · filed 2014-12-23 | |
| 2012-12-31 | $966.59K 10-Q · filed 2014-02-10 | $1.47M derived: sum of 2 quarters · filed 2014-12-23 | $1.93M derived: sum of 3 quarters · filed 2014-12-23 | $2.36M derived: sum of 4 quarters · filed 2014-12-23 | |
| 2012-09-30 | $504.95K derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-23 | $968.26K derived: sum of 2 quarters · filed 2014-12-23 | $1.39M derived: sum of 3 quarters · filed 2014-12-23 | $2.27M 10-K · filed 2014-12-23 | |
| 2012-06-30 | $463.31K 10-Q · filed 2013-08-09 | $886.92K derived: sum of 2 quarters · filed 2013-08-09 | $1.76M 10-Q · filed 2013-08-09 | $2.15M derived: sum of 4 quarters · filed 2013-12-27 | |
| 2012-03-31 | $423.60K 10-Q · filed 2013-05-10 | $1.26M 10-Q · filed 2013-05-10 | $1.69M derived: sum of 3 quarters · filed 2013-12-27 | $2.10M derived: sum of 4 quarters · filed 2013-12-27 | |
| 2011-12-31 | $837.46K 10-Q · filed 2013-02-08 | $1.27M derived: sum of 2 quarters · filed 2013-12-27 | $1.68M derived: sum of 3 quarters · filed 2013-12-27 | ||
| 2011-09-30 | $430.40K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-27 | $837.87K derived: sum of 2 quarters · filed 2013-12-27 | $1.64M 10-K · filed 2013-12-27 | ||
| 2011-06-30 | $407.47K 10-Q · filed 2012-08-09 | $1.21M 10-Q · filed 2012-08-09 | |||
| 2010-09-30 | $1.53M 10-K · filed 2012-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |